A team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called TRAF2 that stops functioning in cancer patients taking the chemotherapy drug doxorubicin, which can result in heart failure.
https://medicalxpress.com/news/2022-11-protein-linked-heart-failure-chemo.html